Temat: "Atherosclerosis" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Synergistic dual cell therapy for atherosclerosis regression: ROS-responsive Bio-liposomes co-loaded with Geniposide and Emodin.
Autorzy:: Li Z; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Zhu H; Department of Pain, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Liu H; Department of Rehabilitation, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.
Liu D; NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan, 750004, China.
Liu J; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Zhang Y; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Qin Z; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Xu Y; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Peng Y; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Ruan L; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Li J; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
He Y; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
Liu B; College of Biology, Hunan University, Changsha, 410082, China. .
Long Y; Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 25; Vol. 22 (1), pp. 129. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Journal Article
MeSH Terms:: Plaque, Atherosclerotic*/drug therapy
Emodin*/pharmacology
Emodin*/therapeutic use
Atherosclerosis*/drug therapy
Atherosclerosis*/metabolism
Iridoids*
Humans ; Liposomes/therapeutic use ; Reactive Oxygen Species/metabolism ; Cholesterol

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ.
Autorzy:: Sanada J; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. .
Kimura T; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Shimoda M; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Iwamoto Y; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Iwamoto H; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Dan K; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Fushimi Y; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Katakura Y; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Nogami Y; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Shirakiya Y; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Yamasaki Y; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Ikeda T; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Nakanishi S; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Mune T; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Kaku K; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Kaneto H; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 19; Vol. 23 (1), pp. 105. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/chemically induced
Atherosclerosis*/drug therapy
Atherosclerosis*/prevention & control
Plaque, Atherosclerotic*
Triazines*
Mice ; Animals ; Streptozocin/therapeutic use ; Mice, Knockout ; Apolipoproteins E/genetics ; Mice, Inbred C57BL

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway.
Autorzy:: Wang H; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Tian Q; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zhang R; Department of Nephrology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Du Q; Jiangyin People's Hospital, Wuxi, Jiangsu, China.; Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, China.
Hu J; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Gao T; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Gao S; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Fan K; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Cheng X; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yan S; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zheng G; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. .; Centre for Transplant and Renal Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia. .
Dong H; Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. .; Pokaż więcej
Źródło:: Lipids in health and disease [Lipids Health Dis] 2024 Mar 11; Vol. 23 (1), pp. 76. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: PPAR gamma*/genetics
PPAR gamma*/metabolism
Atherosclerosis*/drug therapy
Atherosclerosis*/genetics
Atherosclerosis*/metabolism
Flavones*
Animals ; Mice ; Macrophages ; Foam Cells ; Lipoproteins, LDL/pharmacology ; CD36 Antigens/genetics ; CD36 Antigens/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Evaluation of atherosclerotic risk in rosacea patients through serum fetuin-A and carotid intima media thickness.
Autorzy:: Kulaklı S; Department of Dermatology and Venereology, Giresun University Faculty of Medicine, Giresun, Turkey.
Yıldırmak S; Department of Medical Biochemistry, Mersin University Faculty of Medicine, Mersin, Turkey.
Oğuz ID; Department of Dermatology and Venereology, Giresun University Faculty of Medicine, Giresun, Turkey.
Usta M; Department of Medical Biochemistry, Giresun University Faculty of Medicine, Giresun, Turkey.
Tosun A; Department of Radiology, Giresun University Faculty of Medicine, Giresun, Turkey.
Akşan B; Department of Dermatology and Venereology, Giresun University Faculty of Medicine, Giresun, Turkey.; Pokaż więcej
Źródło:: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Mar; Vol. 23 (3), pp. 1075-1084. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/diagnostic imaging
Atherosclerosis*/etiology
Rosacea*/diagnostic imaging
Humans ; alpha-2-HS-Glycoprotein/metabolism ; Biomarkers ; C-Reactive Protein/metabolism ; Carotid Intima-Media Thickness

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process.
Autorzy:: Hachuła M; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
Kosowski M; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
Ryl S; Department of Anaesthesiology and Intensive Care, Municipal Hospital in Zabrze-Biskupice, Zamkowa 4, 41-803 Zabrze, Poland.
Basiak M; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
Okopień B; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 03; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/drug therapy
Atherosclerosis*/metabolism
Diabetes Mellitus, Type 2*/drug therapy
Dyslipidemias*/drug therapy
Glucagon-Like Peptide-1 Receptor*/agonists
Plaque, Atherosclerotic*/drug therapy
Glucagon-Like Peptide-1 Receptor Agonists*/pharmacology
Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use
Humans ; Biomarkers ; Cytokines/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Interleukin-1beta/therapeutic use ; Tumor Necrosis Factor-alpha/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Online application for the diagnosis of atherosclerosis by six genes.
Autorzy:: Zhao Z; Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Chen S; Department of Infectious Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Henan, China.
Wei H; Department of Oncology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ma W; Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Shi W; Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Si Y; Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wang J; Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wang L; Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Li X; Department of Oncology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 10; Vol. 19 (4), pp. e0301912. Date of Electronic Publication: 2024 Apr 10 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*
Atherosclerosis*/diagnosis
Atherosclerosis*/genetics
Humans ; Genes, Essential ; Algorithms ; Databases, Factual

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Autorzy:: Tsioulos G; Fourth Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Kounatidis D; Second Department of Internal Medicine, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vallianou NG; First Department of Internal Medicine, Sismanogleio General Hospital, 15126 Athens, Greece.
Poulaki A; Hematology Unit, Second Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Kotsi E; Second Department of Internal Medicine, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Christodoulatos GS; Department of Microbiology, Sismanogleio General Hospital, 15126 Athens, Greece.
Tsilingiris D; First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Karampela I; Second Department of Critical Care, Attikon General University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Skourtis A; Department of Internal Medicine, Evangelismos General Hospital, 10676 Athens, Greece.
Dalamaga M; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 21; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Cardiovascular Diseases*
Atherosclerosis*/drug therapy
Humans ; Lipoprotein(a)/genetics ; Risk Factors ; Apoprotein(a) ; Apolipoproteins A

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Establishment of a hybrid model of atherosclerosis and acute colitis in ApoE-/- mice.
Autorzy:: Chen K; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.; Department of Ultrasound, Nanjing Drum Tower Hospital, Nanjing, P. R. China.
Zhang S; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.
Cui G; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.
Zhang X; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.
Song Y; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.; Department of Ultrasound, Foshan First People's Hospital, Foshan, P. R. China.
Zheng J; Department of Traditional Chinese Medicine, Peking University Shenzhen Hospital, Shenzhen, P. R. China.
Chen Y; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.
Zheng T; Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, The Hong Kong University of Science and Technology Medical Center, Shenzhen- Peking University, Shenzhen, P. R. China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 18; Vol. 19 (3), pp. e0289820. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/diagnostic imaging
Atherosclerosis*/genetics
Plaque, Atherosclerotic*/diagnostic imaging
Plaque, Atherosclerotic*/complications
Colitis*/complications
Inflammatory Bowel Diseases*/complications
Humans ; Mice ; Animals ; Mice, Knockout ; Mice, Knockout, ApoE ; Diet, High-Fat/adverse effects ; Apolipoproteins E/genetics ; Mice, Inbred C57BL ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Impact of genetic background as a risk factor for atherosclerotic cardiovascular disease: A protocol for a nationwide genetic case-control (CV-GENES) study in Brazil.
Autorzy:: Alves de Oliveira H Junior; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Menezes Neves PDM; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Figueiredo Oliveira GB; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Moreira FR; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Pintão MCT; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Rocha VZ; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
de Souza Rocha C; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Katz VN; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Ferreira EN; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Rojas-Málaga D; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
Viana CF; Department of Research and Development, Fleury Group, São Paulo, São Paulo, Brazil.
da Silva FF; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Vidotti JJ; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Felicio NM; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Araújo Vitor L; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Cesar KG; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Araújo da Silva C; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
de Oliveira Alves LB; Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.
Avezum Á; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0289439. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/genetics
Cardiovascular Diseases*/prevention & control
Atherosclerosis*/genetics
Atherosclerosis*/epidemiology
Humans ; Proprotein Convertase 9 ; Case-Control Studies ; Brazil/epidemiology ; Risk Factors ; Genetic Background ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Investigating the therapeutic effects and mechanisms of Carthamus tinctorius L.-derived nanovesicles in atherosclerosis treatment.
Autorzy:: Yang R; Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.; NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), Shenzhen, China.
Lin F; Department of Cardiology, Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
Wang W; Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences (Shenzhen Sun Yat-sen Cardiovascular Hospital), Shenzhen, China.; Department of Clinical Medicine, University of South China, Hengyang, China.
Dai G; NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), Shenzhen, China.
Ke X; Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences (Shenzhen Sun Yat-sen Cardiovascular Hospital), Shenzhen, China. .
Wu G; Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. .; Guangdong Innovative Engineering and Technology Research Center for Assisted Circulation, Shenzhen, China. .; NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), Shenzhen, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 12; Vol. 22 (1), pp. 178. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carthamus tinctorius*/genetics
Carthamus tinctorius*/metabolism
Cardiovascular Diseases*/metabolism
MicroRNAs*/genetics
Atherosclerosis*/metabolism
Mice ; Animals ; Endothelial Cells/metabolism ; Tissue Distribution ; Mice, Knockout, ApoE ; Inflammation/metabolism ; Apoptosis ; RNA, Messenger/metabolism ; Apolipoproteins E/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Atherosclerosis"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji

Starter badań:

Atherosclerosis.